News Ocular Therapeutix Plunges as Modest Benefit Overshadow Trial Win Over Regeneron’s Eylea by Medscape • 2026/02/17 • 0 Comments Ocular Therapeutix's experimental eye drug showed superiority to Regeneron's Eylea in a key late-stage trial, but its modest advantage and higher rates of certain side... Reuters Health Information